Given that a considerable portion of depressed patients does not respond to or remit during pharmacotherapy, there is increasing interest in non-pharmacological strategies to treat depressive disorders. Several brain stimulation approaches are currently being investigated as novel therapeutic interventions beside electroconvulsive therapy (ECT), a prototypic method in this field with proven effectiveness. These neurostimulation methods include repetitive transcranial magnetic stimulation (rTMS), magnetic seizure therapy (MST), vagus nerve stimulation (VNS), deep brain stimulation (DBS) and transcranial direct current stimulation (tDCS). It is via different neuroanatomically defined “windows” that the various approaches access the neuronal networks showing an altered function in depression. Also, the methods vary regarding their degree of invasiveness. One or the other method may finally achieve antidepressant effectiveness with minimized side effects and constitute a new effective treatment for major depression.
BolwigTG. Putative common pathways in therapeutic brain stimulation for affective disorders. CNS Spectr2003; 8: 490–495.
2.
WahlundBvon RosenD. ECT of major depressed patients in relation to biological and clinical variables: A brief overview. Neuropsychopharmacology2003; 28 (suppl1): S21–S26.
3.
SackeimHA. The anticonvulsant hypothesis of the mechanism of action of ECT: Current status. J ECT1999; 15: 5–26.
4.
SanacoraGMasonGFRothmanDLHyderFCiarciaJJOstroffRB. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry2003; 160: 577–579.
5.
ScottAIDougallNRossMO'CarrollRERiddleWEbmeierKPGoodwinGM. Short-term effects of electroconvulsive treatment on the uptake of 99mTc-exametazime into brain in major depression shown with single photon emission tomography. J Affect Disord1994; 30: 27–34.
6.
BonneOKrauszYShapiraBBocherMKargerHGorfineM. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med1996; 37: 1075–1080.
7.
MervaalaEKononenMFohrJHusso-SaastamoinenMValkonen-KorhonenMKuikkaJT. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord2001; 66: 47–58.
8.
NoblerMSOquendoMAKegelesLSMaloneKMCampbellCCSackeimHAMannJJ. Decreased regional brain metabolism after ect. Am J Psychiatry2001; 158: 305–308.
9.
YathamLNClarkCCZisAP. A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression. J ECT2000; 16: 171–176.
10.
NoblerMSTenebackCCNahasZBohningDEShastriAKozelFAGeorgeMS. Structural and functional neuroimaging of electroconvulsive therapy and transcranial magnetic stimulation. Depress Anxiety2000; 12: 144–156.
11.
Group. UER. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and metaanalysis. Lancet2003; 361: 799–808.
12.
SackeimHAPrudicJDevanandDPKierskyJEFitzsimonsLMoodyBJ. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med1993; 328: 839–846.
13.
CarpenterLL. Neurostimulation in resistant depression. J Psychopharmacol2006; 20: 35–40.
14.
SackeimHAPrudicJNoblerMSLisanbySHDevanandDPPeyserS. Ultra-brief pulse ECT and the affective and cognitive consequences of ECT. J ECT2001; 17: 77.
15.
BarkerATJalinousRFreestonIL. Non-invasive magnetic stimulation of human motor cortex. Lancet1985; 1: 1106–1107.
16.
GeorgeMSLisanbySHSackeimHA. Transcranial magnetic stimulation: Applications in neuropsychiatry. Arch Gen Psychiatry1999; 56: 300–311.
17.
HallettM. Transcranial magnetic stimulation: A tool for mapping the central nervous system. Electroencephalogr Clin Neurophysiol Suppl1996; 46: 43–51.
18.
PadbergFGrossheinrichNZwanzgerP. , Schönfeldt-Lecuona C. Neue Hirnstimulationsverfahren bei Depression. Nervenheilkunde2005; 5: 369–380.
19.
GershonAADannonPNGrunhausL. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry2003; 160: 835–845.
20.
HajakGPadbergFHerwigUEschweilerGWCohrsSLangguthB. Repetitive Transkranielle Magnetstim-ulation: Konsensus zum therapeutischen Einsatz bei psychiatrischen Erkrankungen. Nervenheilkunde2005; 24: 48–58.
21.
PausTCastro-AlamancosMAPetridesM. Cortico-cortical Connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci2001; 14: 1405–1411.
22.
ShajahanPMGlabusMFSteeleJDDorisABAndersonKJenkinsJA. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog Neuropsychopharmacol Biol Psychiatry2002; 26: 945–954.
23.
TenebackCCNahasZSpeerAMMolloyMStallingsLESpicerKM. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci1999; 11: 426–435.
24.
BaxterLRJSchwartzJMPhelpsMEMazziottaJCGuzeBHSelinCE. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry1989; 46: 243–250.
25.
DrevetsWC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res2000; 126: 413–431.
26.
WassermannEMLisanbySH. Therapeutic application of repetitive transcranial magnetic stimulation: A review. Clin Neurophysiol2001; 112: 1367–1377.
27.
WangHWangXScheichH. LTD and LTP induced by transcranial magnetic stimulation on cortico-spinal and cortico-cortical excitability. NeuroReport1996; 7: 521–525. Abstract.
28.
PogarellOKochWPopperlGTatschKJakobFZwanzgerP. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [1231] IBZM SPECT study. J Psychiatr Res2006; 40: 307–314.
29.
O'ReardonJP. Repetitive transcranial magnetic stimulation (rTMS) at 10 Hz in the treatment of pharmacoresistant major depression: results from a controlled multicenter clinical trial. Presented at the 2006 APA Annual Meeting, Toronto, Canada; 2006.
30.
Pascual-LeoneARubioBPallardoFCatalaMD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet1996; 348: 233–237.
31.
AveryDGeorgeMSHoltzheimerPE. The Avery-George-Holtzheimer Database of rTMS Depression Studies. Updated 22.11.04: http://www.ists.unibe.ch/TMSAvery.htm; 2004.
32.
BurtTLisanbySHSackeimHA. Neuropsychiatric applications of transcranial magnetic stimulation: A meta analysis. Int J Neuropsychopharmacol2002; 5: 73–103.
33.
KozelFAGeorgeMS. Meta-Analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatric Pract2002; 8: 270–275.
34.
MartinJLBarbanojMJSchlaepferTEClosSPerezVKulisevskyJGironellA. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev2002; (02): CD003493.
35.
HermannLLEbmeierKP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression. J Clin Psychiatry2006; 67: 1870–1876.
36.
CouturierJL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review and meta-analysis. J Psychiatry Neurosci2005; 30: 83–90.
37.
FitzgeraldPBBrownTLMarstonNADaskalakisZJDe CastellaAKulkarniJ. Transcranial magnetic stimulation in the treatment of depression: A double-blind, placebo-controlled trial. Arch Gen Psychiatry2003; 60: 1002–1008.
38.
GeorgeMSNahasZMolloyMSpeerAMOliverNCLiXB. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry2000; 48: 962–970.
39.
PadbergFZwanzgerPKeckMEKathmannNMikhaielPEllaR. Repetitive transcranial magnetic stimulation (rTMS) in major depression: Relation between efficacy and stimulation intensity. Neuropsychopharmacology2002; 27: 638–645.
40.
KleinEKolskyYPuyerovskyMKorenDChistyakovAFeinsodM. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: A double-blind sham-controlled pilot study. Biol Psychiatry1999; 46: 1451–1454.
41.
PadbergFMöllerH-J. Repetitive transcranial magnetic stimulation: Does it have potential in the treatment of depression?CNS Drugs2003; 17: 383–403.
42.
SackeimHARushAJGeorgeMSMarangellLBHusainMMNahasZ. Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology2001; 25: 713–728.
43.
PadbergFZwanzgerPThomaHKathmannNHaagCGreenbergBD. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: Comparative study of fast, slow and sham rTMS. Psychiatry Res1999; 88: 163–171.
44.
RossiniDMagriLLuccaAGiordaniSSmeraldiEZanardiR. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J Clin Psychiatry2005; 66: 1569–1575.
45.
FitzgeraldPBBenitezJDe CastellaADaskalakisZJBrownTLKulkarniJ. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry2006; 163: 88–94.
46.
GrunhausLDannonPNSchreiberSDolbergOHAmiazRZivRLefkifkerE. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study. Biol Psychiatry2000; 47: 314–324.
47.
AkeckPost ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: What do we know about the neuro-biological mechanisms?J Psychiatr Res2001; 35: 193–215.
48.
NahasZde BruxCChandlerVLorberbaumJPSpeerAMMolloyMA. Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression. J ECT2000; 16: 380–390.
49.
AveryDHHoltzheimerPEIIIFawazWRussoJNeumaierJDunnerDL. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry2006; 59: 187–194.
50.
HausmannAKemmlerGWalpothMMechtcheriakovSKramer-ReinstadlerKLechnerT. No benefit derived from repetitive transcranial magnetic stimulation in depression: A prospective, single centre, randomised, double blind, sham controlled “add on” trial. J Neurol Neurosurg Psychiatry2004; 75: 320–322.
51.
JaruelDDumortierGVerdonCMStamatiadisLSabaGCabaretW. A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): Therapeutic and cognitive effect in medication free unipolar depression during 4 weeks. Prog Neuropsychopharmacol Biol Psychiatry2006; 30: 126–130.
52.
MoserDJJorgeREManesFParadisoSBenjaminMLRobinsonRG. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology2002; 58: 1288–1290.
53.
LittleJTKimbrellTAWassermannEMGrafmanJFiguerasSDunnRT. Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: Preliminary report. Neuropsychiatry Neuropsychol Behav Neurol2000; 13: 119–124.
54.
LooCKSachdevPSElsayedHMcDarmontBNMitchellPBWilkinsonM. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychological functioning, electroencephalogram and auditory threshold in depressed patients. Biol Psychiatry2001; 49: 615–623.
55.
MartisBAlamDDowdSMHillSKSharmaRPRosenC. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol2003; 114: 1125–1132.
56.
SpeerAMKimbrellTAWassermannEMRepellaDWillisMWHerscovitchPPostRM. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry2000; 48: 1133–1141.
57.
TriggsWJMcCoyKJMGreerRRossiFBowersDKortenkampS. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry1999; 45: 1440–1446.
58.
EllaRZwanzgerPStampferRPreussUWMuller-SiechenederFMollerHJPadbergF. Switch to mania after slow rTMS of the right prefrontal cortex. J Clin Psychiatry2002; 63: 249.
59.
ZwanzgerPEllaRKeckMERupprechtRPadbergF. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry2002; 51: 602–603.
60.
LisanbySHLuberBSackeimHAFinckADSchroederC. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry2001; 58: 199–200.
61.
LisanbySHLuberBSchlaepferTESackeimHA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: Randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology2003; 28: 1852–1865.
62.
DworkAJArangoVUnderwoodMLlievskiBRosoklijaGSackeimHALisanbySH. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry2004; 161: 576–578.
63.
LisanbySMoralesOPayneNKwonEFitzsimonsLLuberB. New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr2003; 8: 529–536.
64.
SackeimHARushAJGeorgeMSMarangellLBHusainMMNahasZ. Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology2001; 25: 713–728.
65.
ChaeJHNahasZLomarevMDenslowSLorberbaumJPBohningDEGeorgeMS. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res2003; 37: 443–455.
66.
MarangellLBRushAJGeorgeMSSackeimHAJohnsonCRHusainMM. Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biol Psychiatry2002; 51: 280–287.
67.
RushAJMarangellLBSackeimHAGeorgeMSBrannanSKDavisSM. Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry2005; 58: 347–354.
68.
RushAJSackeimHAMarangellLBGeorgeMSBrannanSKDavisSM. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study. Biol Psychiatry2005; 58: 355–363.
69.
GeorgeMSRushAJMarangellLBSackeimHABrannanSKDavisSM. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry2005; 58: 364–373.
70.
Food and Drug Administration. Summary of Safety and Effectiveness data. VNS Therapy System - P970003s050.2005; www.fda.gov.; 2005.
71.
SchachterSC. Vagus nerve stimulation therapy summary: Five years after FDA approval. Neurology2002; 59: S15–S20.
72.
KoselMSturmVFrickCLenartzDZeidlerGBrodesserDSchlaepferTE. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res2006.
73.
MaybergHSLozanoAMVoonVMcNeelyHESeminowiczDHamaniC. Deep brain stimulation for treatment-resistant depression. Neuron2005; 45: 651–660.
74.
MaybergHSBrannanSKTekellJLSilvaJAMahurinRKMcGinnisSJerabekPA. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry2000; 48: 830–843.
75.
GreenbergBDPriceLHRauchSLFriehsGNorenGMaloneD. Neurosurgery for intractable obsessive-compulsive disorder and depression: Critical issues. Neurosurg Clin N Am2003; 14: 199–212.
76.
GreenbergBFriehsGCarpenterLLTyrkaAMaloneDRezaiA. Deep brain stimulation: Clinical Findings in Intractable Depression and OCD. Neuropsychopharmacology2005; 29: S32.
77.
AlozanoAbosch A. Stereotactic neurosurgery for movement disorders. Can J Neurol Sci2003; 30 (suppl1): S72–S82.
78.
BiksomMInoueMAkiyamaHDeansJKFoxJEMizakawaHJefferysJG. Effects of uniform extracellular DC electric fields on excitability in rat hippocampal slices in vitro. J Physiol2004; 557: 175–180.
79.
LiebetanzDFregniFMonte-SilvaKKOliveiraMBAmanciodos-SantosANitscheMAGuedesRC. After-effects of transcranial direct current stimulation (tDCS) on cortical spreading depression. Neurosci Lett2006; 398: 85–90.
80.
FregniFBoggioPSNitscheMBermpohlFAntalAFeredoesE. Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res2005; 166: 23–30.
81.
NitscheMASeeberAFrommannKKleinCCRochfordCNitscheMS. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol2005; 568: 291–303.
82.
LangNSiebnerHRWardNSLeeLNitscheMAPaulusW. How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain?Eur J Neurosci2005; 22: 495–504.
83.
QuartaroneAMorganteFBagnatoSRizzoVSant'angeloAAielloE. Long lasting effects of transcranial direct current stimulation on motor imagery. NeuroReport2004; 15: 1287–1291.
84.
LiebetanzDNitscheMATergauFPaulusW. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain2002; 125: 2238–2247.
85.
LangNSiebnerHRErnstDNitscheMAPaulusWLemonRNRothwellJC. Preconditioning with transcranial direct current stimulation sensitizes the motor cortex to rapid-rate transcranial magnetic stimulation and controls the direction of after-effects. Biol Psychiatry2004; 56: 634–639.
86.
FregniFThome-SouzaSNitscheMAFreedmanSDValenteKDPascual-LeoneA. A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy. Epilepsia2006; 47: 335–342.
87.
HummelFCelnikPGirauxPFloelAWuWHGerloffCCohenLG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain2005; 128: 490–499.
88.
FregniFBoggioPSNitscheMAMarcolinMARigonattiSPPascual-LeoneA. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord2006; 8: 203–204.
89.
NitscheMALiebetanzDLangNAntalATergauFPaulusW. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin Neurophysiol2003; 114: 2220–2222.
90.
HerwigUPadbergFUngerJSpitzerMSchonfeldt-LecuonaC. Transcranial magnetic stimulation in therapy studies: Examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry2001; 50: 58–61.
